Recursion Pharmaceuticals-A
RXRX · US
Recursion Pharmaceuticals-A is held by 4 of the 24 tracked investors in their latest 13F filings. The largest position is ARK Investment Management's at $152M, 0.98% of that portfolio. Versus the prior quarter, 2 added, 0 trimmed and 1 bought new.
Big investors holding this stock
Latest 13F of the 24 tracked investors. Common shares only.
| Investor | Value ($) | vs prior quarter |
|---|---|---|
| ARK Investment Management weight 0.98% · Q2 2026 |
152M | ▲ 3% |
| Baillie Gifford weight 0.08% · Q2 2026 |
86.2M | – |
| Norges Bank weight 0.00% · Q2 2026 |
25.1M | ▲ 19% |
| Bridgewater Associates weight 0.00% · Q2 2026 |
0.1M | New |
Questions
Which big investors own Recursion Pharmaceuticals-A?
ARK Investment Management ($152M), Baillie Gifford ($86.2M), Norges Bank ($25.1M), Bridgewater Associates ($138,238), per their latest 13F filings.
Does Warren Buffett own Recursion Pharmaceuticals-A?
Berkshire Hathaway did not report it in its latest 13F.
Does Korea's National Pension Service own Recursion Pharmaceuticals-A?
Not in its latest 13F.
Restated and computed from SEC (13F, 13D/G, Form 4) and DART filings and NPS public data. Filings describe a past date and may differ from current holdings (13F: quarter end, up to 45 days later). Not investment advice.
Sources: SEC EDGAR, DART, data.go.kr (NPS), OpenFIGI. See Methodology for how figures are computed.